Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
telazorlimab (ISB 830) / Astria Therap
2018-000783-29: A Study of GBR 830 in Adult Patients with Atopic Dermatitis	Not yet recruiting	2	468	Europe	ISB 830, Powder for solution for infusion	Ichnos Sciences SA, Inchos Sciences SA (renamed from Glenmark Pharmaceuticals SA), Ichnos Sciences SA, Inchos Sciences SA	Moderate to severe atopic dermatitis, Moderate to severe eczema, Diseases [C] - Immune System Diseases [C20]